Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Finance Home
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
The New Investors
All Markets Summit
Give Feedback
Australia markets closed
ALL ORDS
7,137.60
-11.00
(-0.15%)
ASX 200
6,955.20
-13.40
(-0.19%)
AUD/USD
0.6667
-0.0025
(-0.37%)
OIL
68.68
-1.28
(-1.83%)
GOLD
1,988.90
-7.00
(-0.35%)
Bitcoin AUD
42,073.89
+531.00
(+1.28%)
✉️ Sign up
Get our best money-saving hacks and pro tips now
Cerevel Therapeutics Holdings, Inc. (CERE)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
23.43
+0.61
(+2.67%)
At close: 04:00PM EDT
23.43
0.00
(0.00%)
After hours:
04:08PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
280,259
280,259
161,855
103,303
50,294
Selling general and administrative
87,589
87,589
58,243
45,813
33,169
Total operating expenses
367,848
367,848
220,098
149,116
83,463
Operating income or loss
-367,848
-367,848
-220,098
-149,116
-83,463
Total other income/expenses net
6,878
6,878
-5,393
-3,274
-46,433
Income before tax
-351,351
-351,351
-225,334
-152,166
-128,344
Income tax expense
160
160
0
-24
45
Income from continuing operations
-351,511
-351,511
-225,334
-152,142
-128,389
Net income
-351,511
-351,511
-225,334
-152,142
-128,389
Net income available to common shareholders
-351,511
-351,511
-225,334
-152,142
-128,389
Basic EPS
-
-
-1.65
-2.01
-1.01
Diluted EPS
-
-
-1.65
-2.01
-1.01
Basic average shares
-
-
136,577
73,643
127,124
Diluted average shares
-
-
136,577
73,643
127,124
EBITDA
-
-362,945
-217,367
-148,719
-83,286
© 2023 Yahoo. All rights reserved.
Data disclaimer
Help
Suggestions
Terms
Privacy
Privacy Dashboard
About our ads